Sachetta’s GSK GSK Stock Holding History

Sachetta’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300	Closed	-$16.6K	–	1113
2026 Q1	$16.6K	Hold	300	–	–	0.01%	339
2025 Q4	$14.7K	Hold	300	–	–	0.01%	323
2025 Q3	$12.9K	Hold	300	–	–	﹤0.01%	417
2025 Q2	$11.5K	Hold	300	–	–	﹤0.01%	418
2025 Q1	$11.6K	Hold	300	–	–	﹤0.01%	411
2024 Q4	$10.1K	Hold	300	–	–	﹤0.01%	440
2024 Q3	$12.3K	Hold	300	–	–	﹤0.01%	438
2024 Q2	$11.9K	Hold	300	–	–	0.01%	409
2024 Q1	$11.1K	Hold	300	–	–	0.01%	395
2023 Q4	$11.1K	Buy	+300	New	+$10.8K	0.01%	395

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sachetta's GSK Position: Q2 2026 in Review

Sachetta sold out of GSK (GSK) in Q2 2026, closing a stake of 300 shares — an estimated $16.6K sold.

Sachetta first reported a position in GSK in Q4 2023 and held it in 10 quarters. The position peaked at $16.6K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Sachetta reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Sachetta sold 300 GSK shares in Q2 2026, an estimated $16.6K.
Sachetta first reported a position in GSK in Q4 2023 and held it in 10 quarters.
Sachetta's GSK position peaked at $16.6K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.